567
Views
76
CrossRef citations to date
0
Altmetric
Review

Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles

, &
Pages 327-343 | Published online: 18 Jan 2019

References

  • D’CostaVMKingCEKalanLAntibiotic resistance is ancientNature2011477736545746121881561
  • MartinezJLGeneral principles of antibiotic resistance in bacteriaDrug Discov Today Technol201411333924847651
  • McFall-NgaiMHadfieldMGBoschTCAnimals in a bacterial world, a new imperative for the life sciencesProc Natl Acad Sci U S A201311093229323623391737
  • van SchaikWThe human gut resistomePhilos Trans R Soc Lond B Biol Sci201537016702014008725918444
  • DaviesJDaviesDOrigins and evolution of antibiotic resistanceMicrobiol Mol Biol Rev201074341743320805405
  • PotgieterMBesterJKellDBPretoriusEThe dormant blood microbiome in chronic, inflammatory diseasesFEMS Microbiol Rev201539456759125940667
  • NajarMSSaldanhaCLBandayKAApproach to urinary tract infectionsIndian J Nephrol200919412913920535247
  • KellDPotgieterMPretoriusEIndividuality, phenotypic differentiation, dormancy and “persistence” in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiologyF1000Res2015417926629334
  • PintoDSão-JoséCSantosMAChambelLCharacterization of two resuscitation promoting factors of Listeria monocytogenesMicrobiology2013159Pt 71390140123676438
  • LunguBRickeSCJohnsonMGGrowth, survival, proliferation and pathogenesis of Listeria monocytogenes under low oxygen or anaerobic conditions: a reviewAnaerobe2009151–271718926916
  • AudolyGFenollarFLagierJCLepidiHRaoultDDeglycosylation of Tropheryma whipplei biofilm and discrepancies between diagnostic results during Whipple’s disease progressionSci Rep2016612388327025850
  • KimESKimHBKimGKorea INfectious Diseases (KIND) study groupClinical and epidemiological factors associated with methicillin resistance in community-onset invasive Staphylococcus aureus infections: prospective multicenter cross-sectional study in KoreaPLoS One2014912e11412725485895
  • BuchanBWLedeboerNAEmerging technologies for the clinical microbiology laboratoryClin Microbiol Rev201427478382225278575
  • CohenJVincentJLAdhikariNKSepsis: a roadmap for future researchLancet Infect Dis201515558161425932591
  • LafleurLKBishopJDHeinigerEKA rapid, instrument-free, sample-to-result nucleic acid amplification testLab Chip201616193777378727549897
  • DoyleMPLoneraganGHScottHMSingerRSAntimicrobial resistance: challenges and perspectivesCompr Rev Food Sci Food Saf2013122234248
  • WinnickaKWroblewskaMWieczorekPSachaPTTryniszewskaEAThe effect of PAMAM dendrimers on the antibacterial activity of antibiotics with different water solubilityMolecules20131878607861723881050
  • GaoWThamphiwatanaSAngsantikulPZhangLNanoparticle approaches against bacterial infectionsWiley Interdiscip Rev Nanomed Nanobiotechnol20146653254725044325
  • HulmeJRecent advances in the detection of methicillin resistant Staphylococcus aureus (MRSA)BioChip J201711289100
  • XiongMHBaoYYangXZZhuYHWangJDelivery of antibiotics with polymeric particlesAdv Drug Deliv Rev201478637624548540
  • CouvreurPNanoparticles in drug delivery: past, present and futureAdv Drug Deliv Rev2013651212322580334
  • AbedNCouvreurPNanocarriers for antibiotics: a promising solution to treat intracellular bacterial infectionsInt J Antimicrob Agents201443648549624721232
  • WangLHuCShaoLThe antimicrobial activity of nanoparticles: present situation and prospects for the futureInt J Nanomedicine2017121227124928243086
  • PelgriftRYFriedmanAJNanotechnology as a therapeutic tool to combat microbial resistanceAdv Drug Deliv Rev20136513–141803181523892192
  • RaiMIngleAPPanditRBroadening the spectrum of small-molecule antibacterials by metallic nanoparticles to overcome microbial resistanceInt J Pharm2017532113914828870767
  • Torres-SangiaoEHolbanAGestalMCAdvanced nanobiomaterials: vaccines, diagnosis and treatment of infectious diseasesMolecules2016217867
  • CarabineiroSACApplications of gold nanoparticles in nanomedicine: recent advances in vaccinesMolecules2017225E85728531163
  • RizviSMDHussainTAhmedABFGold nanoparticles: a plausible tool to combat neurological bacterial infections in humansBiomed Pharmacother201810771830075371
  • AssoliniJPConcatoVMGonçalvesMDNanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applicationsParasitol Res201711661603161528477099
  • HemegHANanomaterials for alternative antibacterial therapyInt J Nanomedicine2017128211822529184409
  • BaptistaPVMcCuskerMPCarvalhoANano-strategies to fight multidrug resistant bacteria – “A Battle of the Titans”Front Microbiol20189144130013539
  • YangKHanQChenBAntimicrobial hydrogels: promising materials for medical applicationInt J Nanomedicine2018132217226329695904
  • GaoWChenYZhangYZhangQZhangLNanoparticle-based local antimicrobial drug deliveryAdv Drug Deliv Rev2018127465728939377
  • Dos Santos RamosMADa SilvaPBSpósitoLNanotechnology-based drug delivery systems for control of microbial biofilms: a reviewInt J Nanomedicine2018131179121329520143
  • HibbittsAO’LearyCEmerging nanomedicine therapies to counter the rise of methicillin-resistant Staphylococcus aureusMaterials (Basel)2018112E32129473883
  • KhuranaCChudasamaBNanoantibiotics: strategic assets in the fight against drug-resistant superbugsInt J Nanomedicine2018133629593387
  • LiuWdasJMephamAHNemrCRSargentEHKelleySOA fully-integrated and automated testing device for PCR-free viral nucleic acid detection in whole bloodLab Chip201818131928193529881833
  • ChengDYuMFuFDual recognition strategy for specific and sensitive detection of bacteria using aptamer-coated magnetic beads and antibiotic-capped gold nanoclustersAnal Chem201688182082526641108
  • SungYJSukHJSungHYLiTPooHKimMGNovel antibody/gold nanoparticle/magnetic nanoparticle nanocomposites for immunomagnetic separation and rapid colorimetric detection of Staphylococcus aureus in milkBiosens Bioelectron20134343243923370174
  • KumarNKulkarniKBeheraLVermaVPreparation and characterization of maghemite nanoparticles from mild steel for magnetically guided drug therapyJ Mater Sci Mater Med201728811628681216
  • KearnsHGoodacreRJamiesonLEGrahamDFauldsKSERS detection of multiple antimicrobial-resistant pathogens using nanosensorsAnal Chem20178923126661267328985467
  • CowgerTAYangYRinkDEProtein-adsorbed magnetic-nanoparticle-mediated assay for rapid detection of bacterial antibiotic resistanceBioconjug Chem201728489089628192992
  • WeiXZhouWSanjaySTMultiplexed instrument-free bar-chart spinchip integrated with nanoparticle-mediated magnetic aptasensors for visual quantitative detection of multiple pathogensAnal Chem201890169888989630028601
  • GuptaAKNaregalkarRRVaidyaVDGuptaMRecent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applicationsNanomedicine (Lond)200721233917716188
  • CorcheroJLVillaverdeABiomedical applications of distally controlled magnetic nanoparticlesTrends Biotechnol200927846847619564057
  • ChungHJCastroCMImHLeeHWeisslederRA magneto-DNA nanoparticle system for rapid detection and phenotyping of bacteriaNat Nanotechnol20138536937523644570
  • ParkKSKimHKimSNanomagnetic system for rapid diagnosis of acute infectionACS Nano20171111114251143229121461
  • DiekemaDJBeachMLPfallerMAJonesRNSENTRY Participants GroupAntimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin AmericaClin Microbiol Infect20017315215711318814
  • Bubeck WardenburgJWilliamsWAMissiakasDHost defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteinsProc Natl Acad Sci U S A200610337138311383616954184
  • KaimAHWischerTO’ReillyTMR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in ratsRadiology2002225380881412461265
  • LiuJBaiRLiYMRI detection of bacterial brain abscesses and monitoring of antibiotic treatment using bacCESTMagn Reson Med201880266267129577382
  • HoerrVTuchscherrLHüveJBacteria tracking by in vivo magnetic resonance imagingBMC Biol20131116323714179
  • MoroLTuremisMMariniBIppodrinoRGiardiMTBetter together: strategies based on magnetic particles and quantum dots for improved biosensingBiotechnol Adv2017351516327923765
  • VeigasBFernandesARBaptistaPVAuNPs for identification of molecular signatures of resistanceFront Microbiol2014545525221547
  • LawJWAb MutalibNSChanKGLeeLHRapid methods for the detection of foodborne bacterial pathogens: principles, applications, advantages and limitationsFront Microbiol2014577025628612
  • KumarNHuYSinghSMizaikoffBEmerging biosensor platforms for the assessment of water-borne pathogensAnalyst2018143235937329271425
  • MocanTMateaCTPopTDevelopment of nanoparticle-based optical sensors for pathogenic bacterial detectionJ Nanobiotechnology20171512528359284
  • AmendolaVPilotRFrasconiMMaragòOMIatìMASurface plasmon resonance in gold nanoparticles: a reviewJ Phys Condens Matter2017292020300228426435
  • ElghanianRStorhoffJJMucicRCLetsingerRLMirkinCASelective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticlesScience19972775329107810819262471
  • StorhoffJJMarlaSSBaoPGold nanoparticle-based detection of genomic DNA targets on microarrays using a novel optical detection systemBiosens Bioelectron200419887588315128107
  • ChanWSTangBSBoostMVChowCLeungPHDetection of methicillin-resistant Staphylococcus aureus using a gold nanoparticle-based colourimetric polymerase chain reaction assayBiosens Bioelectron20145310511124125759
  • WuS-YHulmeJAnSSARecent trends in the detection of pathogenic Escherichia coli O157:H7BioChip J201593173181
  • TsaiTTHuangCYChenCADiagnosis of tuberculosis using colorimetric gold nanoparticles on a paper-based analytical deviceACS Sens2017291345135428901134
  • CheonSAChoHHKimJLeeJKimHJParkTJRecent tuberculosis diagnosis toward the end TB strategyJ Microbiol Methods2016123516126853124
  • TangLLiJPlasmon-based colorimetric nanosensors for ultrasensitive molecular diagnosticsACS Sens20172785787528750528
  • FoubertABeloglazovaNVRajkovicABioconjugation of quantum dots: review and impact on future applicationTrAC Trends Anal Chem2016833148
  • GoldmanERClappARAndersonGPMultiplexed toxin analysis using four colors of quantum dot fluororeagentsAnal Chem200476368468814750863
  • BanerjeeRJaiswalARecent advances in nanoparticle-based lateral flow immunoassay as a point-of-care diagnostic tool for infectious agents and diseasesAnalyst201814391970199629645058
  • Morales-NarváezENaghdiTZorEMerkoçiAPhotoluminescent lateral-flow immunoassay revealed by graphene oxide: highly sensitive paper-based pathogen detectionAnal Chem201587168573857726205473
  • JinBWangSLinMUpconversion nanoparticles based FRET aptasensor for rapid and ultrasenstive bacteria detectionBiosens Bio-electron201790525533
  • DateAAHanesJEnsignLMNanoparticles for oral delivery: design, evaluation and state-of-the-artJ Control Release201624050452627292178
  • BrooksBDBrooksAETherapeutic strategies to combat antibiotic resistanceAdv Drug Deliv Rev201478142725450262
  • LavermanPDamsETStormGMicroscopic localization of PEG-liposomes in a rat model of focal infectionJ Control Release200175334735511489321
  • TranNHocquetMEonBNon-lamellar lyotropic liquid crystalline nanoparticles enhance the antibacterial effects of rifampicin against Staphylococcus aureusJ Colloid Interface Sci201851910711829486430
  • KalekoMBristolJAHubertSDevelopment of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infectionAnaerobe201641586727262694
  • DicksonRPErb-DownwardJRHuffnagleGBThe role of the bacterial microbiome in lung diseaseExpert Rev Respir Med20137324525723734647
  • SpicerCDJumeauxCGuptaBStevensMMPeptide and protein nanoparticle conjugates: versatile platforms for biomedical applicationsChem Soc Rev201847103574362029479622
  • ChenHLiMLiuZDesign of antibacterial peptide-like conjugated molecule with broad spectrum antimicrobial abilitySci China Chem2018611113117
  • ZhaoXPanFXuHMolecular self-assembly and applications of designer peptide amphiphilesChem Soc Rev20103993480349820498896
  • MitraRNShomeAPaulPDasPKAntimicrobial activity, biocompatibility and hydrogelation ability of dipeptide-based amphiphilesOrg Biomol Chem2009719410219081951
  • Radovic-MorenoAFLuTKPuscasuVAYoonCJLangerRFarokhzadOCSurface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibioticsACS Nano2012654279428722471841
  • CaoBXiaoFXingDHuXPolyprodrug antimicrobials: remarkable membrane damage and concurrent drug release to combat antibiotic resistance of methicillin-resistant Staphylococcus aureusSmall20181441e180200830118562
  • LiuPXuGPranantyoDXuLQNeohK-GKangE-TpH-sensitive zwitterionic polymer as an antimicrobial agent with effective bacterial targetingACS Biomater Sci Eng2018414046
  • MankociSKaiserRLSahaiNBartonHAJoyABactericidal peptidomimetic polyurethanes with remarkable selectivity against Escherichia coliACS Biomater Sci Eng201731025882597
  • JadhavMKalhapureRSRambharoseSNovel lipids with three C18-fatty acid chains and an amino acid head group for pH-responsive and sustained antibiotic deliveryChem Phys Lipids2018212122529305156
  • ChuLGaoHChengTA charge-adaptive nanosystem for prolonged and enhanced in vivo antibiotic deliveryChem Commun (Camb)201652376265626827077219
  • GilliesERFréchetJMpH-Responsive copolymer assemblies for controlled release of doxorubicinBioconjug Chem200516236136815769090
  • KalhapureRSSikwalDRRambharoseSEnhancing targeted antibiotic therapy via pH responsive solid lipid nanoparticles from an acid cleavable lipidNanomedicine20171362067207728434930
  • WangJByrneJDNapierMEDeSimoneJMMore effective nano-medicines through particle designSmall20117141919193121695781
  • HejaziRAmijiMStomach-specific anti-H. pylori therapy; part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbilsInt J Pharm20042721–29910815019073
  • JingZWJiaYYWanNDesign and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pyloriBiomaterials20168427628526851392
  • LuoMJiaYYJingZWConstruction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pyloriColloids Surf B Biointerfaces2018164111929367052
  • KhutoryanskiyVVBeyond PEGylation: alternative surface-modification of nanoparticles with mucus-inert biomaterialsAdv Drug Deliv Rev201812414014928736302
  • HaydenSCZhaoGSahaKAggregation and interaction of cationic nanoparticles on bacterial surfacesJ Am Chem Soc2012134166920692322489570
  • WestmeierDPosseltGHahlbrockANanoparticle binding attenuates the pathobiology of gastric cancer-associated Helicobacter pyloriNanoscale20181031453146329303193
  • YuHGuoCFengBTriple-layered pH-responsive micelleplexes loaded with siRNA and cisplatin prodrug for NF-Kappa B targeted treatment of metastatic breast cancerTheranostics201661142726722370
  • RahmeLGStevensEJWolfortSFShaoJTompkinsRGAusubelFMCommon virulence factors for bacterial pathogenicity in plants and animalsScience19952685219189919027604262
  • SuYZhaoLMengFWangQYaoYLuoJSilver nanoparticles decorated lipase-sensitive polyurethane micelles for on-demand release of silver nanoparticlesColloids Surf B Biointerfaces201715223824428113126
  • ChenYLZhuSZhangLSmart conjugated polymer nanocarrier for healthy weight loss by negative feedback regulation of lipase activityNanoscale2016863368337526790821
  • XuLHeCHuiLBactericidal dendritic polycation cloaked with stealth material via lipase-sensitive intersegment acquires neutral surface charge without losing membrane-disruptive activityACS Appl Mater Interfaces2015750276022760726632646
  • YangSHanXYangYBacteria-targeting nanoparticles with microenvironment-responsive antibiotic release to eliminate intracellular Staphylococcus aureus and associated infectionACS Appl Mater Interfaces20181017142991431129633833
  • RezaeeRTalebrezaAZiariKBehnodVEmampourBFSDistribution of virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli isolated from diabetic and healthy males suffered from urinary tract infectionsBiosci Biotechnol Res Asia2016132931937
  • LimYMde GroofAJCBhattacharjeeMKFigurskiDHSchonEABacterial conjugation in the cytoplasm of mouse cellsInfect Immun200876115110511918765719
  • MarshallTGLeeREMarshallFECommon angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2bTheor Biol Med Model200631116403216
  • Pires-LapaMCarvalho-SousaCCeconEFernandesPMarkusRβ-adrenoceptors trigger melatonin synthesis in phagocytesInt J Mol Sci2018198E218230049944
  • ProalADAlbertPJMarshallTGBlaneyGPLindsethIAImmu-nostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitisImmunol Res2013562–339841223576059
  • AksungurPDemirbilekMDenkbaşEBVandervoortJLudwigAUnlüNDevelopment and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studiesJ Control Release2011151328629421241752
  • MohammadiGNokhodchiABarzegar-JalaliMPhysicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery systemColloids Surf B Biointerfaces2011881394421752610
  • GiannavolaCBucoloCMalteseAInfluence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailabilityPharm Res200320458459012739765
  • CouvreurPFattalEAlphandaryHPuisieuxFAndremontAIntracellular targeting of antibiotics by means of biodegradable nanoparticlesJ Control Release1992191–3259267
  • RanjanAPothayeeNSeleemMDrug delivery using novel nanoplexes against a Salmonella mouse infection modelJ Nanopart Res2010123905914
  • SosnikACarcabosoAMGlisoniRJMorettonMAChiappettaDANew old challenges in tuberculosis: potentially effective nanotechnologies in drug deliveryAdv Drug Deliv Rev2010624–554755919914315
  • RawalTButaniSCombating tuberculosis infection: a forbidding challengeIndian J Pharm Sci201678181627168676
  • ChewNYChanHKUse of solid corrugated particles to enhance powder aerosol performancePharm Res200118111570157711758765
  • LawlorCKellyCO’LearySCellular targeting and trafficking of drug delivery systems for the prevention and treatment of MTbTuberculosis (Edinb)2011911939721237714
  • PandeyRSharmaAZahoorASharmaSKhullerGKPrasadBPoly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosisJ Antimicrob Chemother200352698198614613962
  • FangGLiWShenXDifferential Pd-nanocrystal facets demonstrate distinct antibacterial activity against Gram-positive and Gram-negative bacteriaNat Commun20189112929317632
  • ChoiSKMycASilpeJEDendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surfaceACS Nano20137121422823259666
  • YuMWangHFuFDual-recognition Förster resonance energy transfer based platform for one-step sensitive detection of pathogenic bacteria using fluorescent vancomycin-gold nanoclusters and aptamer-gold nanoparticlesAnal Chem20178974085409028287715
  • SilveroCMJRoccaDMde La VillarmoisEASelective photo-induced antibacterial activity of amoxicillin-coated gold nanoparticles: from one-step synthesis to in vivo cytocompatibilityACS Omega2018311220123030023798
  • ZhuMLiuWLiuHConstruction of Fe3O4/Vancomycin/PEG magnetic nanocarrier for highly efficient pathogen enrichment and gene sensingACS Appl Mater Interfaces2015723128731288126005899
  • WangCZhangKZhouZVancomycin-modified Fe(3)O(4)@SiO(2)@Ag microflowers as effective antimicrobial agentsInt J Nanomedicine2017123077309428450783
  • CapelettiLBLoiolaLMDPiccoASda Silva LiberatoMCardosoMB8 – Silica nanoparticle applications in the biomedical fieldCiofaniGSmart Nanoparticles for BiomedicineElsevier2018115129
  • KimYParkEJNaDHRecent progress in dendrimer-based nano-medicine developmentArch Pharm Res201841657158229450862
  • WuSDuanNQiuYLiJWangZColorimetric aptasensor for the detection of Salmonella enterica serovar typhimurium using ZnFe2O4-reduced graphene oxide nanostructures as an effective peroxidase mimeticsInt J Food Microbiol2017261424828910678
  • AngsantikulPThamphiwatanaSZhangQCoating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infectionAdv Ther (Weinh)201812180001630320205
  • MuppidiKWangJBetageriGPumerantzASPEGylated liposome encapsulation increases the lung tissue concentration of vancomycinAntimicrob Agents Chemother201155104537454221788465
  • KalhapureRSSonawaneSJSikwalDRSolid lipid nanoparticles of clotrimazole silver complex: an efficient nano antibacterial against Staphylococcus aureus and MRSAColloids Surf B Biointerfaces201513665165826492156
  • PeiYMohamedMFSeleemMNYeoYParticle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophagesJ Control Release201726713314328797580
  • PuisneyCBaeza-SquibanABolandSMechanisms of uptake and translocation of nanomaterials in the lungAdv Exp Med Biol20181048213629453530
  • BerçotBPoirelLDortetLNordmannPIn vitro evaluation of antibiotic synergy for NDM-1-producing EnterobacteriaceaeJ Antimicrob Chemother201166102295229721807739
  • JohnsonTJSiekKEJohnsonSJNolanLKDNA sequence of a ColV plasmid and prevalence of selected plasmid-encoded virulence genes among avian Escherichia coli strainsJ Bacteriol2006188274575816385064
  • SercombeLVeeratiTMoheimaniFWuSYSoodAKHuaSAdvances and challenges of liposome assisted drug deliveryFront Pharmacol2015612728626648870
  • DeolPKhullerGKJoshiKTherapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in miceAntimicrob Agents Chemother1997416121112149174172
  • RuckmaniKSankarVSivakumarMTissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomesJ Biomed Nanotechnol201061435120499831
  • HuangCTStewartPSReduction of polysaccharide production in Pseudomonas aeruginosa biofilms by bismuth dimercaprol (BisBAL) treatmentJ Antimicrob Chemother199944560160510552975
  • MahdiunFMansouriSKhazaeliPMirzaeiRThe effect of tobramycin incorporated with bismuth-ethanedithiol loaded on niosomes on the quorum sensing and biofilm formation of Pseudomonas aeruginosaMicrob Pathog201710712913528323149
  • ChitambarCRGallium and its competing roles with iron in biological systemsBiochim Biophys Acta2016186382044205327150508
  • HammerNDSkaarEPMolecular mechanisms of Staphylococcus aureus iron acquisitionAnnu Rev Microbiol201165112914721639791
  • OhSHParkHSKimHSAntimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogensInt J Antimicrob Agents20175070070628668680
  • GoderskaKAgudo PenaSAlarconTHelicobacter pylori treatment: antibiotics or probioticsAppl Microbiol Biotechnol201810211729075827
  • TrifanAGirleanuICojocariuCPseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradicationWorld J Gastroenterol201319427476747924259981
  • MiernykKMBulkowLRGoldBDPrevalence of Helicobacter pylori among Alaskans: factors associated with infection and comparison of urea breath test and anti-Helicobacter pylori IgG antibodiesHelicobacter2018233e1248229537130
  • WangYKKuoFCLiuCJDiagnosis of Helicobacter pylori infection: current options and developmentsWorld J Gastroenterol20152140112211123526523098
  • RamtekeSGaneshNBhattacharyaSJainNKTriple therapy-based targeted nanoparticles for the treatment of Helicobacter pyloriJ Drug Target200816969470518982518
  • CamargoMCGarcíaARiquelmeAThe problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin AmericaAm J Gastroenterol2014109448549524589670
  • LiXXShiSRongLFengMQZhongLThe impact of liposomal linolenic acid on gastrointestinal microbiota in miceInt J Nanomedicine2018131399140929563795
  • MullaneKFidaxomicin in Clostridium difficile infection: latest evidence and clinical guidanceTher Adv Chronic Dis201452698424587892
  • XuKLiangZCDingXNanomaterials in the prevention, diagnosis, and treatment of Mycobacterium tuberculosis infectionsAdv Healthc Mater2018711700509
  • AiXHuMWangZRecent advances of membrane-cloaked nanoplatforms for biomedical applicationsBioconjug Chem201829483885129509403
  • HuCMFangRHLukBTZhangLPolymeric nanotherapeutics: clinical development and advances in stealth functionalization strategiesNanoscale201461657524280870
  • EscajadilloTOlsonJLukBTZhangLNizetVA red blood cell membrane-camouflaged nanoparticle counteracts streptolysin O-mediated virulence phenotypes of invasive Group A StreptococcusFront Pharmacol2017847728769806
  • CharoenpholPOswaltKBishopCJTherapeutics incorporating blood constituentsActa Biomater201873648029626699
  • ZhangYZhangJChenWErythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infectionJ Control Release201726318519128087406
  • ChenYChenMZhangYBroad-spectrum neutralization of pore-forming toxins with human erythrocyte membrane-coated nanospongesAdv Healthc Mater2018713e170136629436150
  • WeiXGaoJWangFIn situ capture of bacterial toxins for antivirulence vaccinationAdv Mater201729331701644
  • FangRHLukBTHuCMZhangLEngineered nanoparticles mimicking cell membranes for toxin neutralizationAdv Drug Deliv Rev201590698025868452
  • JiangYFangRHZhangLBiomimetic nanosponges for treating antibody-mediated autoimmune diseasesBioconjug Chem201829487087729357234
  • YukSASanchez-RodriguezDATsifanskyMDYeoYRecent advances in nanomedicine for sepsis treatmentTher Deliv20189643545029722636
  • DasSAngsantikulPLeCNeutralization of cholera toxin with nanoparticle decoys for treatment of choleraPLoS Negl Trop Dis2018122e000626629470490
  • GaoWFangRHThamphiwatanaSModulating antibacterial immunity via bacterial membrane-coated nanoparticlesNano Lett20151521403140925615236
  • ShenHAckermanALCodyVEnhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticlesImmunology20061171788816423043
  • SongCNohYWLimYTPolymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune responseInt J Nanomedicine2016113753376427540289
  • BaficaAScangaCAFengCGLeiferCCheeverASherATLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosisJ Exp Med2005202121715172416365150
  • WeissDSRaupachBTakedaKAkiraSZychlinskyAToll-like receptors are temporally involved in host defenseJ Immunol200417274463446915034062
  • LuDGarcia-ContrerasLXuDPoly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85BPharm Res200724101834184317657598
  • CaiHHuXDYuDHLiSXTianXZhuYXCombined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of miceVaccine200523324167417415908060
  • PriyadarsiniSMukherjeeSMishraMNanoparticles used in dentistry: a reviewJ Oral Biol Craniofac Res201881586729556466
  • KadiyalaUTurali-EmreESBahngJHKotovNAVanEppsJSUnexpected insights into antibacterial activity of zinc oxide nanoparticles against methicillin resistant Staphylococcus aureus (MRSA)Nanoscale201810104927493929480295
  • De MatteisVExposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro/in vivo toxicity evaluationToxics201754E2929051461
  • BreznanDdasDDO’BrienJSDifferential cytotoxic and inflammatory potency of amorphous silicon dioxide nanoparticles of similar size in multiple cell linesNanotoxicology201711222323528142331
  • JainAKSenapatiVASinghDDubeyKMauryaRPandeyAKImpact of anatase titanium dioxide nanoparticles on mutagenic and genotoxic response in Chinese hamster lung fibroblast cells (V-79): the role of cellular uptakeFood Chem Toxicol201710512713928400324
  • VimbelaGVNgoSMFrazeCYangLStoutDAAntibacterial properties and toxicity from metallic nanomaterialsInt J Nanomedicine2017123941396528579779
  • PanáčekASmékalováMKilianováMStrong and nonspecific synergistic antibacterial efficiency of antibiotics combined with silver nanoparticles at very low concentrations showing no cytotoxic effectMolecules2015211E2626729075
  • ThorsingMBentinTGivskovMTolker-NielsenTGoltermannLThe bactericidal activity of β-lactam antibiotics is increased by metabolizable sugar speciesMicrobiology2015161101999200726243263
  • RahmanTYarnallBDoyleDAEfflux drug transporters at the forefront of antimicrobial resistanceEur Biophys J201746764765328710521
  • StokesJMMacNairCRIlyasBPentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistanceNat Microbiol2017251702828263303
  • MelanderRJMelanderCThe challenge of overcoming antibiotic resistance: an adjuvant approach?ACS Infect Dis20173855956328548487
  • WuSYParkGYKimSHHulmeJAnSSADiminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7Drug Des Devel Ther20161033633378
  • MiltonMEMinrovicBMHarrisDLRe-sensitizing multi-drug resistant bacteria to antibiotics by targeting bacterial response regulators: characterization and comparison of interactions between 2-aminoimidazoles and the response regulators BfmR from Acinetobacter baumannii and QseB from Francisella sppFront Mol Biosci201851529487854
  • JamilBHabibHAbbasiSAIhsanANasirHImranMDevelopment of cefotaxime impregnated chitosan as nano-antibiotics: de novo strategy to combat biofilm forming multi-drug resistant pathogensFront Microbiol2016733027047457
  • MengJHeGWangHReversion of antibiotic resistance by inhibiting mecA in clinical methicillin-resistant Staphylococci by antisense phosphorothioate oligonucleotideJ Antibiot201568315816425269464
  • BikardDEulerCWJiangWExploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobialsNat Biotechnol201432111146115025282355
  • LuoMLLeenayRTBeiselCLCurrent and future prospects for CRISPR-based tools in bacteriaBiotechnol Bioeng2016113593094326460902
  • GiauVVLeeHShimKHBagyinszkyEAnSSAGenome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer’s diseaseClin Interv Aging20181322123329445268